Article info

Download PDFPDF
Original article
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results

Authors

  1. Correspondence to Dr Tim Wyant, Takeda Pharmaceuticals International Co, 40 Landsdowne St, Cambridge, MA 02139, USA; Tim.Wyant{at}takeda.com
View Full Text

Citation

Wyant T, Leach T, Sankoh S, et al
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results

Publication history

  • Received February 25, 2014
  • Revised April 2, 2014
  • Accepted April 3, 2014
  • First published April 24, 2014.
Online issue publication 
December 08, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.